Viewing Opinion | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.


Opinion for Becton Dickinson (BDX-N)

Signal Price Bias Subject Owned

This started a long time ago making syringes and needles, and that’s pretty much been their core. It’s all consumables in the hospitals, etc. Just made a recent acquisition of CR Bard (BCR-N) in the urology business. Both companies generate consistently growing free cash flows. There’s a 10% bump to the dividend every year. This merger is going to give them some debt that should be paid off within the next 2 years. He likes the company at this price.

David Driscoll
President & CEO, Liberty International Investment Management Inc

No Comments.

You must be logged in to comment.